The Neuron Specific Enolase (NSE) test is primarily used for diagnosing and monitoring neuroendocrine cancers, assessing neurological damage—especially in conditions such as small cell lung cancer, brain injury, and stroke—as well as tracking disease progression and treatment effectiveness in neurological disorders